Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07545837
- Status
- Recruiting
Conditions
- Thyroid Gland Follicular Carcinoma
- Thyroid Gland Papillary Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Counseling — OTHERAttend HWC sessions
- Interview — OTHERAncillary studies
- Questionnaire Administration — OTHERAncillary studies
Study Details
This clinical trial evaluates the impact of a patient-centered health and wellness coaching (HWC) intervention on adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer. Treatment for thyroid cancer often involves surgery, radioactive iodine and/or lifelong levothyroxine with regular monitoring of thyroid stimulating hormone levels. Despite strong survival rates, patients frequently report fatigue, cognitive issues, mood changes, and disruptions in daily life. Treatment burden and psychosocial strain often impair the ability to follow the treatment plan and healthy lifestyle. Studies have shown that HWC motivates patients to take ownership and accountability to perform positive and healthy behavioral changes. HWC may have a positive impact on health-related goal-setting processes and improve self-care and healthcare outcomes in certain settings. It is not yet known how HWC impacts thyroid cancer patients. Incorporating HWC into survivorship care may improve adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer.
Key Dates
- First listed
- Apr 22, 2026
- Start date
- Jun 23, 2026
- Status verified
- Jul 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Supportive care (HWC)Patients attend an initial HWC session over 60 minutes and then attend follow-up HWC sessions over 20-60 minutes each monthly for up to 5 months.
Primary Outcome Measure
Recruitment rate [ Time Frame: Up to 1 year ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
- Megan Warner904-953-0476
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | Megan Warner 904-953-0476 Abd Moain Abu Dabrh, MB, BCh, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid CancerRecruiting · Mayo Clinic · Rochester, Minnesota
- Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E MutationPHASE2 · Recruiting · City of Hope Medical Center · Duarte, California
- Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA TrialNot Yet Recruiting · University of Michigan Rogel Cancer Center · Ann Arbor, Michigan